Nucleotides supplementation may improve sleep quality in older adults aged 60-70 years
The TALENTs trial is a randomized, double-blinded, placebo-controlled study evaluating nucleotides as an anti-aging supplement in 122 older adults (mean age 65.65 years, 67.21% female). Baseline data showed that nearly half of participants had room for improvement in sleep quality, and sleep quality was measured as a secondary outcome at 2 and 4 months.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Nucleotides supplementation may improve sleep quality in older adults aged 60-70 years The current body of evidence comprises 1 study, including 1 randomized controlled trial. EvidenceHub rates the overall confidence at 42/100 (low).
The Claim
Nucleotides supplementation may improve sleep quality in older adults aged 60-70 years
This conclusion is most relevant to: Community-dwelling older adults aged 60-70 years, predominantly female, with pre-frailty and at least one chronic condition.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Targeting Aging and Longevity with Exogenous Nucleotides (TALENTs): Rationale, Design, and Baseline Characteristics from a Randomized Controlled Trial in Older Adults. (Nutrients, 2024) —
How It Works
The proposed biological pathway:
- ▸Nucleotides are involved in cellular processes
- ▸Nucleotides may reduce oxidative stress and inflammation
- ▸Improved cellular function may support sleep regulation
- ▸Result: Potential improvement in sleep quality
Who Might Benefit
Evidence fit by population:
- ▸Community-dwelling older adults aged 60-70 years, predominantly female, with pre-frailty and at least one chronic condition
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Baseline data only; no post-intervention results reported yet
- ▸Sleep quality is a secondary outcome, not primary, limiting statistical power for this specific claim
- ▸Nearly half of participants had room for improvement, but baseline sleep quality was not severely impaired
Frequently Asked Questions
What is the TALENTs trial?▼
TALENTs is a randomized, double-blinded, placebo-controlled trial testing nucleotides as an anti-aging supplement in adults aged 60-70 years.
How was sleep quality measured in this study?▼
Sleep quality was assessed as part of a comprehensive geriatric health assessment at baseline, 2 months, and 4 months.
Did the study find that nucleotides improve sleep?▼
The abstract reports baseline characteristics only; results on sleep quality changes after intervention are not yet available.
Who were the participants in this trial?▼
122 community-dwelling adults aged 60-70 years, mostly female (67.21%), with pre-frailty and at least one chronic condition.
References
- 1.Wang S, Song L, Fan R, Chen Q, You M, Cai M, Wu Y, Li Y, Xu M. “Targeting Aging and Longevity with Exogenous Nucleotides (TALENTs): Rationale, Design, and Baseline Characteristics from a Randomized Controlled Trial in Older Adults..” Nutrients, 2024. PMID: 38732590 DOI: 10.3390/nu16091343